- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Acute Lymphoblastic Leukemia
Medical specialists from France tagged as investigators in clinical trials studying Acute Lymphoblastic Leukemia
Total 76 results
-
Paul Saultier, M.D.Seen in:
- Marseille Cedex 5, CHU de Marseille - Hôpital de la Timone
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Pauline Simon, M.D.Seen in:
- Besancon Cedex 03, CHRU Besançon
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Philippe RousselotSeen in:
- Ile-de-france, Le Chesnay, Centre Hospitalier de Versailles Hôpital Andre Mignot
- Le Chesnay, Hôpital Mignot
Trials:- NCT04797780 (Principal Investigator)
- NCT03589326 (Principal Investigator)
-
Pierre-Simon Rohrlich, M.D.Seen in:
- Nice, CHU Nice - Hôpital l'Archet 2
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Raynier Devillier, MD,PhDSeen in:
- Bouches-du-Rhône, Marseille, Institut Paoli-Calmettes
Trials:- NCT03235973 (Principal Investigator)
Conditions: -
Sandrine Thouvenin-Doulet, M.D.Seen in:
- SAINT ETIENNE Cedex 02, CHU Saint Etienne Hopital Nord
- Saint-Étienne, CHU Saint Etienne Hopital Nord
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Stéphane Ducassou, M.D.Seen in:
- Bordeaux Cedex, CHU Bordeaux - Groupe Hospitalier Pellegrin
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Stephanie De BottonSeen in:
- Villejuif, Institut Gustave Roussy-Gustave Roussy Cancer Center -DITEP
Trials:- NCT04065399 (Principal Investigator)
-
Stéphanie Haouy, M.D.Seen in:
- Montpellier Cedex 5, CHU de Montpellier - Hôpital Arnaud de Villeneuve
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Thierry ODENT, MD-PhDSeen in:
- Tours, Service de chirurgie orthopédique pédiatrique -CHRU TOURS
Trials:- NCT05792007 (Principal Investigator)
-
Virginie GandemerSeen in:
- Ille-et-Vilaine, Rennes, CHRU Rennes
- Ille-et-Vilaine, Rennes, CHU de Rennes - Hôpital Pontchaillou
- Ille-et-Vilaine, Rennes, Hopital Sud
- Rennes Cedex 2, CHU Rennes - Hôpital sud
- Rennes, CHU de Rennes, Serive d'Onco-Pédiatrie
Trials:- NCT04501614 (Principal Investigator)
- NCT05319353 (Principal Investigator)
- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
-
Wadih Abou Chahla, M.D.Seen in:
- Lille Cedex, CHRU de Lille - Hôpital Jeanne de Flandre
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Yves Bertrand, MD PhDSeen in:
- Lyon, IHOP / Lyon, Service Hématologie et d'Oncologie pédiatrique
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Yves Reguerre, M.D.Seen in:
- Saint-Denis, CHU De La Réunion - Site Nord (Hôpital Félix GUYON)
Trials:- NCT04307576 (Principal Investigator)
Conditions:
Clinical Trials on Acute Lymphoblastic Leukemia
-
National Cancer Institute (NCI)CompletedB-cell Adult Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...United States
-
Autolus LimitedCompletedCD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (AMELIA)Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | B-cell Acute Lymphoblastic Leukemia | Refractory Childhood Acute Lymphoblastic LeukemiaUnited Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI); ImmunoGen, Inc.WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent...
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Non-T, Non-B Childhood Acute Lymphoblastic LeukemiaUnited States
-
University College, LondonNot yet recruitingAcute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved Remission
-
University of BirminghamAstraZeneca; Cancer Research UKTerminatedAcute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia RecurrentUnited Kingdom, Denmark, Netherlands
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinRecruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia Recurrent | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved RemissionUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States